"2238 GMT [Dow Jones] Strong organic growth was the highlight of Monash IVF's (MVF.AU) interim result, says Macquarie. "Although acquisitions did boost the top-line, organic growth was still impressive at 14.7%." The company, which operates more than 20 fertility clinics and ultrasound clinics in Australia and one fertility clinic in Malaysia, grew market share and increased prices during the period. New ventures are also starting to perform, with the Malaysia operation growing volumes by 14%, leading to a search to find larger premises. The broker lifts its price target by 11% to A$2 a share. "Although industry growth will unlikely stay at these lofty levels, we see upside risk to our mid-single digit EPS growth forecasts from international expansion, acquisitions and potential further share gains." ([email protected]; @beckthurlow)"
MVF Price at posting:
$1.63 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)